In the BioHarmony Drug Report Database

"Preview" Icon

Elotuzumab

Empliciti (elotuzumab) is an antibody pharmaceutical. Elotuzumab was first approved as Empliciti on 2015-11-30. It is used to treat multiple myeloma in the USA. It has been approved in Europe to treat multiple myeloma. The pharmaceutical is active against SLAM family member 7.

 

Trade Name

 

Empliciti
 

Common Name

 

elotuzumab
 

ChEMBL ID

 

CHEMBL1743010
 

Indication

 

multiple myeloma
 

Drug Class

 

Monoclonal antibodies: humanized, tumors as target

Image (chem structure or protein)

Elotuzumab structure rendering